Research Articles
IHC Validation in Precision Medicine: A Comprehensive Guide for Stratifying Patients in Clinical Trials
This article provides a detailed guide for researchers and drug development professionals on validating immunohistochemistry (IHC) assays for robust patient stratification in clinical trials.
Beyond the Checklist: How Adopting CAP IHC Validation Guidelines Elevates Research Reproducibility and Drug Development
This article provides a comprehensive analysis of the impact of adopting the College of American Pathologists (CAP) guidelines for immunohistochemistry (IHC) assay validation.
Achieving Multi-Site Reproducibility in IHC: A Complete Guide to Robust Assay Development
This comprehensive guide addresses the critical challenge of ensuring immunohistochemistry (IHC) assay robustness and reproducibility across multiple laboratory sites in research and drug development.
Navigating IHC Assay Revalidation: A Comprehensive Guide to Triggers, Procedures, and Best Practices
This definitive guide provides researchers, scientists, and drug development professionals with a detailed framework for immunohistochemistry (IHC) assay revalidation.
Navigating IHC Regulatory Compliance: A Strategic Guide for Researchers and Drug Developers
This guide provides a comprehensive roadmap for researchers and drug development professionals to navigate the complex regulatory landscape of Immunohistochemistry (IHC) assays.
IHC Platform Selection Guide 2025: Dako vs. Leica vs. Ventana for Precision Research & Diagnostics
This comprehensive guide provides researchers, scientists, and drug development professionals with a critical analysis for selecting an immunohistochemistry (IHC) assay platform.
IHC Assay Development for Precision Medicine: A Complete Guide for Biomarker Validation and Clinical Translation
This article provides a comprehensive roadmap for researchers, scientists, and drug development professionals engaged in developing robust immunohistochemistry (IHC) assays for precision medicine applications.
IHC Assay Concordance Rates: A Comparative Analysis of Automation Platforms and Clinical Implications
Immunohistochemistry (IHC) is a cornerstone of diagnostic pathology and biomarker discovery in drug development.
Understanding IHC Concordance Rates: CLIA vs CAP Requirements for Clinical & Research Labs
This article provides a comprehensive guide for researchers, scientists, and drug development professionals on the critical requirements for Immunohistochemistry (IHC) assay concordance rates under the Clinical Laboratory Improvement Amendments (CLIA)...
IHC in Cancer Research: A Comprehensive Guide to Biomarker Detection for Precision Oncology
Immunohistochemistry (IHC) remains a cornerstone technology for cancer biomarker detection, providing critical spatial and protein-level information for research, drug development, and diagnostic applications.